D. E. Shaw & Co., Inc. Meridian Bioscience Inc Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$30.9 - $33.55 $315,180 - $342,210	10,200 New	10,200 $322,000
Q2 2021 Aug 16, 2021	SELL	$18.01 - $28.32 $204,359 - $321,347	-11,347 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$19.76 - $29.89 $224,216 - $339,161	11,347 New	11,347 $298,000
Q4 2020 Feb 16, 2021	SELL	$15.73 - $21.66 $535,354 - $737,176	-34,034 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$13.54 - $26.41 $1.85 Million - $3.61 Million	-136,560 Reduced 80.05%	34,034 $578,000
Q2 2020 Aug 14, 2020	SELL	$7.84 - $23.29 $3.68 Million - $10.9 Million	-469,401 Reduced 73.34%	170,594 $3.97 Million
Q1 2020 May 15, 2020	BUY	$5.57 - $11.5 $58,975 - $121,762	10,588 Added 1.68%	639,995 $5.38 Million
Q4 2019 Feb 14, 2020	SELL	$7.9 - $10.14 $82,152 - $105,445	-10,399 Reduced 1.63%	629,407 $6.15 Million
Q3 2019 Nov 14, 2019	BUY	$9.17 - $12.01 $182,739 - $239,335	19,928 Added 3.21%	639,806 $6.07 Million
Q2 2019 Aug 14, 2019	BUY	$10.88 - $17.6 $2.56 Million - $4.14 Million	235,171 Added 61.13%	619,878 $7.36 Million
Q1 2019 May 15, 2019	BUY	$15.51 - $17.61 $7,243 - $8,223	467 Added 0.12%	384,707 $6.78 Million
Q4 2018 Feb 14, 2019	BUY	$14.52 - $19.72 $584,226 - $793,453	40,236 Added 11.7%	384,240 $6.67 Million
Q3 2018 Nov 14, 2018	BUY	$14.85 - $16.35 $947,979 - $1.04 Million	63,837 Added 22.79%	344,004 $5.13 Million
Q2 2018 Aug 14, 2018	BUY	$13.8 - $16.8 $1.12 Million - $1.36 Million	80,960 Added 40.64%	280,167 $4.46 Million
Q1 2018 May 15, 2018	BUY	$13.8 - $16.2 $352,921 - $414,298	25,574 Added 14.73%	199,207 $2.83 Million
Q4 2017 Feb 14, 2018	BUY	$13.55 - $15.8 $1.67 Million - $1.95 Million	123,155 Added 243.98%	173,633 $2.43 Million
Q3 2017 Nov 14, 2017	BUY	$13.45 - $14.35 $678,929 - $724,359	50,478	50,478 $722,000

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account